Toronto, ON, May 26, 2025 (GLOBE NEWSWIRE) -- With National Smile Day around the corner, new research from Sensodyne, the #1 dentist-recommended brand for sensitive teeth, reveals that more than 80 per cent of Canadians want whiter teeth, but for many, sensitivity and cost are standing in the way. The recent survey in partnership with Harris Poll, showed that 40 per cent have resorted to TikTok trend alternatives like baking soda, activated charcoal and oil pulling to get the results they want, but these of ...

At Investors' Edge, we specialise in identifying undervalued companies with strong fundamentals and great growth potential. Our rigorous value investing approach combines thorough fundamental analysis with a focus on companies trading significantly below their intrinsic value.We prioritise businesses with robust cash flows, strong balance sheets, and competent management teams while maintaining a long-term investment horizon that allows our thesis to materialise. Through disciplined research and patience, w ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F Commission File No. 001-41411 ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-41411 Haleon plc (Translation of registrant's name into English) Building 5, First Floor, The Heights, Weybridge, Surrey, KT13 0NY (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20 ...

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or ...

Core Viewpoint - Haleon Plc reported a slight decline in revenue for 2024, reflecting challenges in the consumer healthcare market, particularly in cold and flu product demand [1][2]. Financial Performance - Revenue for 2024 was reported at 11.23 billion pounds (US$14.19 billion), down 0.6% compared to the previous year [1]. - Adjusted operating profit for 2024 was 2.5 billion pounds, a decrease of 6.5% at constant currency [1]. - Organic revenue growth was 5.0%, driven by a 3.7% increase in price and a 1.3% increase in volume/mix, with a notable 6.8% organic growth in Q4 [1]. Segment Performance - Oral Health revenue increased by 5.6% to 3.3 billion pounds, with organic revenue growth of 9.6% [5]. - Vitamins, Minerals, and Supplements revenue rose by 3.4% to 1.7 billion pounds, with organic growth of 7.6%, including 8.2% organic growth in Q4 [5]. - Pain Relief revenue declined by 3.3%, with flat organic growth of 0.1%, totaling 2.6 billion pounds [5]. - Respiratory Health revenue decreased by 3.4% to 1.7 billion pounds, with organic revenue growth of 0.9% [5]. - Digestive Health and Other revenue fell by 7.2% to 2 billion pounds [2]. Future Guidance - The company projects organic revenue growth for 2025 to be between 4% and 6%, with expectations for growth to be weighted towards the second half of the year [3][4]. - A foreign exchange translation headwind of approximately 1.0% and 2.5% is expected to negatively impact net revenue and adjusted operating profit [3]. Market Reaction - Haleon Plc's stock (HLN) was down 4.12% at $9.78 during the premarket session [4].

Haleon plc (NYSE:HLN) Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ET Company Participants Jo Russell - Head-Investor Relations Brian McNamara - Chief Executive Officer Dawn Allen - Chief Financial Officer Conference Call Participants Guillaume Delmas - UBS David Hayes - Jefferies Rashad Kawan - Morgan Stanley Chris Pitcher - Redburn Tom Sykes - Deutsche Bank Jo Russell Good morning, everyone. Welcome to Haleon's Full Year 2024 Q&A call. I'm Jo Russell, Head of Investor Relations. And I'm join ...

2024 Full year results February 2025 Disclaimer This presentation contains certain statements that are, or may be deemed to be, "forward-looking statements" (including for purposes of the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934). Forward-looking statements give Haleon's current expectations and projections about future events, including strategic initiatives and future financial condit ...

Marketing Campaign - TUMS has partnered with DraftKings to launch the TUMS Fantasy Foodball Pool, a free-to-play game where participants can win a share of $40,000 in cash prizes by selecting their top six food and drink choices from a menu of 36 items [1] - The campaign features food-related themes such as Tailgate Foods, Spicy Foods, Sweet Foods, and New Orleans Foods, aligning with the Big Game season [6] - TUMS has collaborated with former professional football champion Vince Wilfork, who shares his personal experience with heartburn relief and promotes the brand [2][3] Consumer Insights - A survey of 2,000 Americans revealed that 54% believe gameday food is crucial to the overall experience, with barbecue (34%), hot wings (33%), and seven-layer dip (24%) being the top three most popular foods [1] - 1 in 4 survey respondents cited heartburn as a potential outcome of enjoying gameday foods, and 1 in 3 hope their host has an antacid on hand [1] Product Promotion - TUMS Chewy Bites and Gummy Bites are highlighted as effective solutions for occasional heartburn, sour stomach, acid indigestion, and upset stomach relief [6][7] - The company emphasizes that TUMS is the 1 recommended antacid brand by doctors, pharmacists, and OBGYNs, and is America's 1 antacid with a variety of flavors and formats [7] Event Activation - TUMS will host an event in New Orleans during Big Game Weekend at Bourbon Heat on Feb 7, offering samples of TUMS Chewy Bites, exclusive merchandise, and giveaways, while also promoting the final round of the TUMS Fantasy Foodball Pool [4] Brand Collaboration - DraftKings and TUMS are continuing their successful partnership, leveraging the popularity of food during football watch parties to engage fans with a competitive and interactive experience [4]

Core Insights - Haleon has appointed Joe Sta-Romana as Chief Customer Officer for its US business, effective December 1, 2024, to lead customer strategy and drive growth in the US market [1][2]. Leadership Experience - Joe Sta-Romana brings over 20 years of experience in the FMCG sector, having previously led Unilever's Walmart business and held significant roles at P&G and Unilever, focusing on sales and category management [2][3]. Strategic Focus - The new CCO will implement customer-focused strategies, utilizing improved data analytics and digital solutions to enhance partnerships with key retailers, ensuring Haleon remains a trusted partner [3][4]. Company Vision - Haleon's mission is to deliver better everyday health with humanity, emphasizing the importance of understanding customer challenges to provide tailored solutions [4][5]. Product Portfolio - Haleon operates in six major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, Wellness, and Sexual Wellness, with a diverse range of well-known brands [5].